Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
Special Offer: Just $199
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:QLGN

Qualigen Therapeutics - QLGN Price Target & Analyst Ratings

$1.85
+0.05 (+2.78%)
(As of 11/25/2022 08:58 PM ET)
Add
Compare
Today's Range
$1.78
▼
$1.85
50-Day Range
$0.17
▼
$1.85
52-Week Range
$1.54
▼
$29.70
Volume
8,700 shs
Average Volume
53,875 shs
Market Capitalization
$71.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Qualigen Therapeutics Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

$4.00
116.22% Upside
High Prediction$4.00
Average Prediction$4.00
Low Prediction$4.00
TypeCurrent
11/28/21 to 11/28/22		1 Month Ago
10/29/21 to 10/29/22		3 Months Ago
8/30/21 to 8/30/22		1 Year Ago
11/28/20 to 11/28/21
Consensus RatingN/AN/A
Buy
Buy
Strong Buy N/A N/A
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy N/A N/A
1 Buy rating(s)
1 Buy rating(s)
Hold N/A N/A
0 Hold rating(s)
0 Hold rating(s)
Sell N/A N/A
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$4.00N/A$6.50$6.50
Predicted Upside116.22% UpsideN/A322.08% Upside322.08% Upside
Get Qualigen Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter.


QLGN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

QLGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Qualigen Therapeutics Stock vs. The Competition

TypeQualigen TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
0.00
2.66
2.48
Consensus RatingN/ABuyHold
Predicted Upside116.22% Upside760.82% Upside12.75% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating		 Outperform Votes
7
87.50%
Underperform Votes
1
12.50%
Avg. Outperform Votes
163
66.26%
Avg. Underperform Votes
83
33.74%
Avg. Outperform Votes
853
68.19%
Avg. Underperform Votes
398
31.81%

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/21/2022Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$4.00+1,939.68%
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












QLGN Price Target - Frequently Asked Questions

Do MarketBeat users like Qualigen Therapeutics more than its competitors?

MarketBeat users like Qualigen Therapeutics more than other Medical companies. 87.50% of MarketBeat users gave Qualigen Therapeutics an outperform vote while medical companies recieve an average of 66.39% outperform votes by MarketBeat users.

Does Qualigen Therapeutics's stock price have much upside?

According to analysts, Qualigen Therapeutics's stock has a predicted upside of 1,939.78% based on their 12-month price targets.

What analysts cover Qualigen Therapeutics?

Qualigen Therapeutics has been rated by Alliance Global Partners in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (NASDAQ:QLGN) was last updated on 11/28/2022 by MarketBeat.com Staff